Atherosclerosis
·
May 20, 2025
Epigenetic mechanisms underlying variation of IL-6, a well-established inflammation biomarker and risk factor for cardiovascular disease.
Lappalainen Lab
Tuuli Lappalainen’s lab studies functional genetic variation in human populations. It is particularly interested in regulatory variation affecting the transcriptome, as well as cellular mechanisms underlying genetic associations to disease. The lab integrates computational analysis of genomic and transcriptomic data with population genetic and experimental analysis.
Tuuli Lappalainen, PhD
Senior Associate Faculty Member, NYGC
Director, National Genomics Infrastructure, SciLifeLab; Professor, KTH School of Engineering Sciences in Chemistry, Biotechnology and Health; Former Assistant Professor, Department of Systems Biology, Columbia University
Latest News & Publications
Biology, Genomics & Technology Support The Lappalainen Lab
To support our work, please click below and specify ‘The Lappalainen Lab’ in the designation field.
